Vitrolife Q2: A distinct positive surprise and a big step in the right direction - Redeye

Despite a softer period for Vitrolife’s typically reliable Consumables and APAC, the company delivers a distinct positive surprise during Q2. The overall growth was 4%, with a positive outcome. The critical question is whether Vitrolife is now firmly on track to reinstalling a growth rate closer to its long-term target of >10%. We look forward to the call and expect a robust >5% positive share price reaction.

Länk till analysen i sin helhet: https://www.redeye.se/research/1022626/vitrolife-q2-vitrolife-q2-a-distinct-positive-surprise-and-a-big-step-in-the-right-direction?utm_source=finwire&utm_medium=RSS